Follow-up study of LDH patients participated in the Phase II/III study (6603/1021) and Phase III study (6603/1031) of condoliase (SI-6603)

Trial Profile

Follow-up study of LDH patients participated in the Phase II/III study (6603/1021) and Phase III study (6603/1031) of condoliase (SI-6603)

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Mar 2015

At a glance

  • Drugs Condoliase (Primary)
  • Indications Intervertebral disc displacement
  • Focus Therapeutic Use
  • Sponsors Seikagaku Corporation
  • Most Recent Events

    • 10 Mar 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
    • 29 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top